Cytokine expression of microscopic colitis including interleukin-17

Gut and Liver

Volumn 9, Issue 3, 2015, Pages 381-387

  Park, Eunkyoung ^a   Park, Young Sook ^a   Park, Dae Rim ^a   Jung, Sung Ae ^b   Han, Dong Soo ^c   Jang, Byung Ik ^d   Kim, Young Ho ^e   Kim, Won Ho ^f   Jo, Yun Ju ^a   Lee, Ki Ho ^a   Lee, Won Mi ^a   Kim, Eun Kyung ^a   Koo, Hae Soo ^b  

^a Eulji University School of Medicine   (South Korea)

^b Ewha Womans University School of Medicine   (South Korea)

^c Hanyang University   (South Korea)

^d Yeungnam University College of Medicine   (South Korea)

^e Sungkyunkwan University School of Medicine   (South Korea)

^f Yonsei University College of Medicine   (South Korea)

Author keywords

Colitis, collagenous; Colitis, lymphocytic; Colitis, microscopic; Immunohistochemistry

Indexed keywords

CYCLOOXYGENASE 2; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 17; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE; TUMOR NECROSIS FACTOR;

ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL EVALUATION; COLLAGENOUS COLITIS; COLON BIOPSY; COMPARATIVE STUDY; CONTROLLED STUDY; DIARRHEA; DISEASE ASSOCIATION; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY BOWEL DISEASE; INFLAMMATORY CELL; LYMPHOCYTIC COLITIS; MICROSCOPIC COLITIS; MICROSCOPY; PATHOGENESIS; STAINING; BIOPSY; COLON; INTESTINE MUCOSA; METABOLISM; PATHOLOGY;

BIOPSY; COLITIS, MICROSCOPIC; COLON; CYCLOOXYGENASE 2; CYTOKINES; DIARRHEA; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-17; INTESTINAL MUCOSA; NF-KAPPA B; NITRIC OXIDE SYNTHASE TYPE II; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84929520389     PISSN: 19762283     EISSN: 20051212     Source Type: Journal    
DOI: 10.5009/gnl13439     Document Type: Article

References (27)

1. Andresen L, Jørgensen VL, Perner A, Hansen A, Eugen-Olsen J, Rask-Madsen J. Activation of nuclear factor kappaB in colonic mucosa from patients with collagenous and ulcerative colitis. Gut 2005;54:503-509.
2. Kao KT, Pedraza BA, McClune AC, et al. Microscopic colitis: a large retrospective analysis from a health maintenance organization experience. World J Gastroenterol 2009;15:3122-3127.
3. Loftus EV. Microscopic colitis: epidemiology and treatment. Am J Gastroenterol 2003;98(12 Suppl):S31-S36.
4. Thomson RD, Lestina LS, Bensen SP, Toor A, Maheshwari Y, Ratcliffe NR. Lansoprazole-associated microscopic colitis: a case series. Am J Gastroenterol 2002;97:2908-2913.
5. Yagi K, Nakamura A, Sekine A, Watanabe H. Nonsteroidal anti-inflammatory drug-associated colitis with a histology of collagenous colitis. Endoscopy 2001;33:629-632.
6. Tagkalidis PP, Gibson PR, Bhathal PS. Microscopic colitis demonstrates a T helper cell type 1 mucosal cytokine profile. J Clin Pathol 2007;60:382-387.
7. Perner A, Andresen L, Normark M, et al. Expression of nitric oxide synthases and effects of L-arginine and L-NMMA on nitric oxide production and fluid transport in collagenous colitis. Gut 2001;49:387-394.
8. Wildt S, Rumessen JJ, Csillag C, Normark M, Poulsen KA, Kolko M. Cyclooxygenase-2 immunoreactivity in collagenous colitis. APMIS 2009;117:500-506.
9. Lazenby AJ, Yardley JH, Giardiello FM, Jessurun J, Bayless TM. Lymphocytic ("microscopic") colitis: a comparative histopathologic study with particular reference to collagenous colitis. Hum Pathol 1989;20:18-28.
10. Giardiello FM, Lazenby AJ. The atypical colitides. Gastroenterol Clin North Am 1999;28:479-490, x.
11. Jessurun J, Yardley JH, Giardiello FM, Hamilton SR, Bayless TM. Chronic colitis with thickening of the subepithelial collagen layer (collagenous colitis): histopathologic findings in 15 patients. Hum Pathol 1987;18:839-848.
12. Dey I, Beck PL, Chadee K. Lymphocytic colitis is associated with increased pro-inflammatory cytokine profile and up regulation of prostaglandin receptor EP4. PLoS One 2013;8:e61891.
13. Wallace JL. Prostaglandin biology in inflammatory bowel disease. Gastroenterol Clin North Am 2001;30:971-980.
14. Hendel J, Nielsen OH. Expression of cyclooxygenase-2 mRNA in active inflammatory bowel disease. Am J Gastroenterol 1997;92: 1170-1173.
15. Müller-Decker K, Albert C, Lukanov T, Winde G, Marks F, Fürstenberger G. Cellular localization of cyclo-oxygenase isozymes in Crohn's disease and colorectal cancer. Int J Colorectal Dis 1999;14:212-218.
16. Singer II, Kawka DW, Schloemann S, Tessner T, Riehl T, Stenson WF. Cyclooxygenase 2 is induced in colonic epithelial cells in inflammatory bowel disease. Gastroenterology 1998;115:297-306.
17. Roberts PJ, Morgan K, Miller R, Hunter JO, Middleton SJ. Neuronal COX-2 expression in human myenteric plexus in active inflammatory bowel disease. Gut 2001;48:468-472.
18. Kumawat AK, Strid H, Tysk C, Bohr J, Hörnquist EH. Microscopic colitis patients demonstrate a mixed Th17/Tc17 and Th1/Tc1 mucosal cytokine profile. Mol Immunol 2013;55:355-364.
19. Kim SW, Kim ES, Moon CM, et al. Genetic polymorphisms of IL-23R and IL-17A and novel insights into their associations with inflammatory bowel disease. Gut 2011;60:1527-1536.
20. Zhang Z, Zheng M, Bindas J, Schwarzenberger P, Kolls JK. Critical role of IL-17 receptor signaling in acute TNBS-induced colitis. Inflamm Bowel Dis 2006;12:382-388.
21. Strzepa A, Szczepanik M. IL-17-expressing cells as a potential therapeutic target for treatment of immunological disorders. Pharmacol Rep 2011;63:30-44.
22. Fitzpatrick LR. Novel pharmacological approaches for inflammatory bowel disease: targeting key intracellular pathways and the IL-23/IL-17 axis. Int J Inflam 2012;2012:389404.
23. Casellas i Jordà F. TNF-alpha inhibitors in inflammatory bowel disease. Med Clin (Barc) 2004;123:627-634.
24. Ullman TA, Itzkowitz SH. Intestinal inflammation and cancer. Gastroenterology 2011;140:1807-1816.
25. Malik T, Mannon P. Inflammatory bowel diseases: emerging therapies and promising molecular targets. Front Biosci (Schol Ed) 2012;4:1172-1189.
26. Esteve M, Mahadevan U, Sainz E, Rodriguez E, Salas A, Fernández-Bañares F. Efficacy of anti-TNF therapies in refractory severe microscopic colitis. J Crohns Colitis 2011;5:612-618.
27. Aram G, Bayless TM, Chen ZM, Montgomery EA, Donowitz M, Giardiello FM. Refractory lymphocytic enterocolitis and tumor necrosis factor antagonist therapy. Clin Gastroenterol Hepatol 2010;8:391-394.